435 related articles for article (PubMed ID: 21764469)
21. Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group.
Cohn JN; Fowler MB; Bristow MR; Colucci WS; Gilbert EM; Kinhal V; Krueger SK; Lejemtel T; Narahara KA; Packer M; Young ST; Holcslaw TL; Lukas MA
J Card Fail; 1997 Sep; 3(3):173-9. PubMed ID: 9330125
[TBL] [Abstract][Full Text] [Related]
22. Different impact of carvedilol and transdermal scopolamine on cardiovascular performance of mild-moderate chronic heart failure patients: evidence of useful effects of scopolamine on tolerance to work load.
De Vecchis R; Pucciarelli G; Setaro A; Nocerino L
Minerva Cardioangiol; 2000 Nov; 48(11):393-410. PubMed ID: 11214431
[TBL] [Abstract][Full Text] [Related]
23. Effect of β-blocker cessation on chronotropic incompetence and exercise tolerance in patients with advanced heart failure.
Hirsh BJ; Mignatti A; Garan AR; Uriel N; Colombo P; Sims DB; Jorde UP
Circ Heart Fail; 2012 Sep; 5(5):560-5. PubMed ID: 22855557
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol.
Guazzi M; Agostoni P; Matturri M; Pontone G; Guazzi MD
Am Heart J; 1999 Sep; 138(3 Pt 1):460-7. PubMed ID: 10467196
[TBL] [Abstract][Full Text] [Related]
25. Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis.
Yue-Chun L; Teng Z; Na-Dan Z; Li-Sha G; Qin L; Xue-Qiang G; Jia-Feng L
PLoS One; 2012; 7(6):e39394. PubMed ID: 22761780
[TBL] [Abstract][Full Text] [Related]
26. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
[TBL] [Abstract][Full Text] [Related]
27. Impact of 6 months of therapy with carvedilol on muscle sympathetic nerve activity in heart failure patients.
De Matos LD; Gardenghi G; Rondon MU; Soufen HN; Tirone AP; Barretto AC; Brum PC; Middlekauff HR; Negrão CE
J Card Fail; 2004 Dec; 10(6):496-502. PubMed ID: 15599840
[TBL] [Abstract][Full Text] [Related]
28. CArdiac resynchronization in combination with beta blocker treatment in advanced chronic heart failure (CARIBE-HF): the results of the CARIBE-HF study.
Grosu A; Senni M; Iacovoni A; Gori M; Cantù F; Bisetti S; De Santo T; De Luca A; Gavazzi A
Acta Cardiol; 2011 Oct; 66(5):573-80. PubMed ID: 22032050
[TBL] [Abstract][Full Text] [Related]
29. Heart failure in a district general hospital: are target doses of beta-blockers realistic?
Mehta PA; McDonagh S; Poole-Wilson PA; Grocott-Mason R; Dubrey SW
QJM; 2004 Mar; 97(3):133-9. PubMed ID: 14976270
[TBL] [Abstract][Full Text] [Related]
30. [The effects of mid- and long-term administration (3-4 years) of carvedilol in patients with idiopathic dilated cardiomyopathy].
Metra M; Nodari S; Garbellini M; Boldi E; Rosselli F; Milan E; Giubbini R; Dei Cas L
Cardiologia; 1997 May; 42(5):503-12. PubMed ID: 9289367
[TBL] [Abstract][Full Text] [Related]
31. Heart rate manipulation in dilated cardiomyopathy: Assessing the role of Ivabradine.
Raja DC; Kapoor A; Sinha A; Kashyap S; Khanna R; Kumar S; Garg N; Tewari S; Goel P
Indian Heart J; 2018; 70(2):246-251. PubMed ID: 29716702
[TBL] [Abstract][Full Text] [Related]
32. [Long-term outcome and tolerability of carvedilol therapy in Japanese patients with chronic heart failure].
Kawashiro N; Matsuda N; Endo Y; Uchida Y; Kasanuki H
J Cardiol; 2006 May; 47(5):229-37. PubMed ID: 16764329
[TBL] [Abstract][Full Text] [Related]
33. Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure.
Demopoulos L; Yeh M; Gentilucci M; Testa M; Bijou R; Katz SD; Mancini D; Jones M; LeJemtel TH
Circulation; 1997 Apr; 95(7):1764-7. PubMed ID: 9107160
[TBL] [Abstract][Full Text] [Related]
34. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
[TBL] [Abstract][Full Text] [Related]
35. Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol.
Nessler J; Nessler B; Kitliński M; Gackowski A; Piwowarska W; Stepniewski M
Kardiol Pol; 2008 Feb; 66(2):144-51; discussion 152-3. PubMed ID: 18344152
[TBL] [Abstract][Full Text] [Related]
36. The effects of chronic carvedilol therapy on QT dispersion in patients with congestive heart failure.
Yildirir A; Sade E; Tokgozoglu L; Oto A
Eur J Heart Fail; 2001 Dec; 3(6):717-21. PubMed ID: 11738224
[TBL] [Abstract][Full Text] [Related]
37. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
Kosmala W; Holland DJ; Rojek A; Wright L; Przewlocka-Kosmala M; Marwick TH
J Am Coll Cardiol; 2013 Oct; 62(15):1330-8. PubMed ID: 23916925
[TBL] [Abstract][Full Text] [Related]
38. Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registry.
Abraham WT; Massie BM; Lukas MA; Lottes SR; Nelson JJ; Fowler MB; Greenberg B; Gilbert EM; Franciosa JA;
Congest Heart Fail; 2007; 13(1):16-21. PubMed ID: 17268206
[TBL] [Abstract][Full Text] [Related]
39. Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure.
Macdonald PS; Keogh AM; Aboyoun CL; Lund M; Amor R; McCaffrey DJ
J Am Coll Cardiol; 1999 Mar; 33(4):924-31. PubMed ID: 10091817
[TBL] [Abstract][Full Text] [Related]
40. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy.
Metra M; Nardi M; Giubbini R; Dei Cas L
J Am Coll Cardiol; 1994 Dec; 24(7):1678-87. PubMed ID: 7963115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
